Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Bluejay Diagnostics, Inc. (BJDX) had Stock-Based Compensation of $-0.00M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-1.96M |
|
-- |
|
-- |
|
$1.99M |
|
$-1.99M |
|
$0.03M |
|
$-1.96M |
|
$-1.96M |
|
$-1.96M |
|
$-1.96M |
|
$-1.96M |
|
$-1.96M |
|
$-1.99M |
|
$-1.95M |
|
1.39M |
|
1.39M |
|
$-1.41 |
|
$-1.41 |
|
| Balance Sheet Financials | |
$4.75M |
|
$1.48M |
|
$1.65M |
|
$6.40M |
|
$1.04M |
|
-- |
|
$0.07M |
|
$1.11M |
|
$5.29M |
|
$5.29M |
|
$5.29M |
|
1.49M |
|
| Cash Flow Statement Financials | |
$-3.24M |
|
-- |
|
$3.38M |
|
$4.30M |
|
$4.44M |
|
$0.14M |
|
|
Stock-Based Compensation |
$-0.00M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.56 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.24M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-36.99% |
|
-36.99% |
|
-30.56% |
|
-36.99% |
|
$3.54 |
|
$-2.33 |
|
$-2.33 |
|